Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q3 2025 value amounting to $9651.0.

  • Cumberland Pharmaceuticals' Gains from Investment Securities rose 10195.46% to $9651.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$431503.0, marking a year-over-year increase of 6318.86%. This contributed to the annual value of -$1.5 million for FY2024, which is 1650.64% down from last year.
  • Cumberland Pharmaceuticals' Gains from Investment Securities amounted to $9651.0 in Q3 2025, which was up 10195.46% from $38602.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities registered a high of $5.6 million during Q4 2022, and its lowest value of -$983574.0 during Q3 2022.
  • Over the past 5 years, Cumberland Pharmaceuticals' median Gains from Investment Securities value was -$230430.0 (recorded in 2024), while the average stood at $126432.1.
  • In the last 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities soared by 79241.13% in 2022 and then crashed by 17224.37% in 2023.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Gains from Investment Securities stood at $632319.0 in 2021, then skyrocketed by 792.41% to $5.6 million in 2022, then tumbled by 104.18% to -$236128.0 in 2023, then crashed by 122.22% to -$524732.0 in 2024, then surged by 101.84% to $9651.0 in 2025.
  • Its last three reported values are $9651.0 in Q3 2025, $38602.0 for Q2 2025, and $44976.0 during Q1 2025.